Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Nan Li
Assistant Professor
Radiation Oncology
https://orcid.org/0000-0001-5391-0532
h-index
1516
Citations
16
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2014
2024
Research activity per year
Overview
Fingerprint
Network
Research output
(21)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Nan Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
53BP1
25%
AMPK Signaling
25%
Angiomotin
25%
Breast Cancer Susceptibility Gene 1 (BRCA1)
25%
Cancer Detection
50%
Cell Cycle-dependent
25%
Detection Sensitivity
16%
EGFR mutation
25%
Family Protein
25%
FOXK2
16%
Human Epidermal Growth Factor Receptor 2-negative
25%
Inflammatory Breast Cancer
25%
KRAS mutant
25%
Label-free Imaging
50%
Liver Kinase B1 (LKB1)
50%
Low-density Lipoprotein Receptor-related protein-1 (LRP1)
25%
Lung Cancer
15%
Metabolic Homeostasis
25%
Nanoaperture
50%
Neoadjuvant Chemotherapy
25%
Non-small Cell Lung Cancer (NSCLC)
35%
Notch Pathway
25%
One Sample
16%
Panitumumab
25%
PARP Inhibitor (PARPi)
50%
Pathological Complete Response
22%
Pathway Activation
25%
Pexophagy
25%
Plasmonics
50%
Poly(ADP-ribose)
33%
Poly(ADP-ribose) Polymerase
31%
Poor Clinical Outcomes
25%
Protein-protein Interaction Network
25%
Proteomic Analysis
25%
Pyruvate Kinase M2 (PKM2)
25%
RAD50
25%
Radiosensitization
25%
Radiotherapy
29%
Resectable Lung Cancer
25%
Reverse Phase Protein Array
15%
RNF146
25%
Small Extracellular Vesicles
50%
Tankyrase
100%
Tankyrase Inhibitor
44%
Targeted Therapeutics
25%
Trametinib
25%
Tumor
14%
Tumor Growth
30%
Tumorigenesis
30%
Ubiquitin Variants
25%
Biochemistry, Genetics and Molecular Biology
Acetylation
12%
Adenosine Diphosphate Ribose
12%
ADP-ribosylation
25%
AMP-activated Protein Kinase
50%
AMPK Signaling
25%
BRCA1
25%
Cancer Cell
11%
Carcinogenesis
28%
Cas9
25%
Catenin
30%
Cell Cycle
25%
Cell Proliferation
16%
Chromosome 10
12%
Colon
12%
CRISPR
25%
Dishevelled
25%
Downregulation
16%
Enzyme
13%
Epidermal Growth Factor Receptor
25%
Fibrinogen
12%
G1 Phase
12%
G2 Phase
16%
Genome Editing
10%
Guide RNA
15%
Homeostasis
36%
LDL Receptor
25%
Lipoprotein Receptor-Related Protein
25%
Mitochondrial Dynamics
25%
Notch
25%
Pexophagy
25%
Phosphatase
25%
Phosphatidylinositol (3,4,5)-trisphosphate
12%
Phosphoproteomics
25%
PKM2
25%
Poly ADP Ribose Polymerase
46%
Posttranslational Modification
25%
Protein Family
25%
Protein Interaction
28%
Protein Stability
12%
Proteome
25%
Proteomics
25%
Small Extracellular Vesicles
25%
Sumoylation
12%
Synapsin I
25%
Tensin
12%
Tumor Progression
32%
Tumor Suppressor Protein
22%
Ubiquitin Ligase
33%
Ubiquitin-Conjugating Enzyme
12%
Ubiquitination
32%
Medicine and Dentistry
Biological Marker
8%
Cancer
7%
Cancer Cell
21%
Cancer Diagnosis
50%
Cancer Therapy
30%
Cancer Treatment
6%
Cas9
25%
Cell Damage
6%
Chemoradiotherapy
25%
Clustered Regularly Interspaced Short Palindromic Repeat
25%
Combination Therapy
6%
Cytotoxic T-Cell
6%
Diagnosis
10%
Distant Metastasis
6%
Epidermal Growth Factor Receptor 2
25%
Gamma Urogastrone
25%
Genome Editing
10%
Guide RNA
15%
Immune Checkpoint Blockade
12%
Immune System
12%
Immunocompetent Cell
12%
Immunosurveillance
6%
Immunotherapy
25%
In Vitro
12%
Inflammatory Breast Cancer
25%
Ipilimumab
6%
Lung Cancer Cell Line
7%
Malignant Neoplasm
35%
Medicine
25%
Melanoma
6%
Monotherapy
6%
Neoadjuvant Chemotherapy
25%
Neoplasm
35%
Non Small Cell Lung Cancer
30%
Panitumumab
25%
PARP Inhibitor
25%
Phosphoprotein
7%
Poly ADP Ribose Polymerase
25%
Protein Microarray
10%
Radiation Therapy
75%
Radiation-Induced Cancer
6%
Radiosensitivity
10%
Sensitization
25%
Stromal Cell
6%
Tankyrase Inhibitor
15%
Tissue Microarray
7%
Toxicity
10%
Tumor Antigen
6%
Tumor Cell
6%
Tumor Microenvironment
6%